Peterson Katharine (CIK 0002022214)

Latest company ownership

ACRV - Acrivon Therapeutics, Inc.

Role: Chief Accounting Officer

Shares held

4,122

Last filed at

Nov 18, 2025

Confidence Score

47.5

2025Q4

Confidence Score History

2024Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 14, 2025	Nov 18, 2025	Acrivon Therapeutics, Inc.	Chief Accounting Officer	Sell	47.5	-99	-2.35%	✗	$221.8
Aug 14, 2025	Aug 18, 2025	Acrivon Therapeutics, Inc.	Chief Accounting Officer	Sell	47.5	-99	-2.29%	✗	$137.6
May 14, 2025	May 16, 2025	Acrivon Therapeutics, Inc.	Chief Accounting Officer	Sell	47.5	-99	-2.24%	✗	$112.9
Feb 14, 2025	Feb 19, 2025	Acrivon Therapeutics, Inc.	Chief Accounting Officer	Sell	47.5	-116	-2.56%	✗	$628.7
Nov 14, 2024	Nov 18, 2024	Acrivon Therapeutics, Inc.	Chief Accounting Officer	Sell	47.5	-99	-2.14%	✗	$784.1
Aug 14, 2024	Aug 16, 2024	Acrivon Therapeutics, Inc.	Chief Accounting Officer	Sell	47.5	-99	-2.09%	✗	$695
May 14, 2024	May 16, 2024	Acrivon Therapeutics, Inc.	Chief Accounting Officer	Sell	47.5	-99	-2.05%	✗	$827.6